News

Research Updates: Recent NBTS-Funded Research The ultimate goal of scientific endeavor in the field of cancer research is to advance discoveries made in the laboratory through the translational and pre-clinical research process to become new medicines patients can take in the clinic. But as scientific discoveries and advancements occur, it is also important that results from studies be published in […] April 20, 2016

From the CEO’s Desk: Moving Deeper Into the Brain Tumor Precision Medicine Era Last week, a colleague sent me a news story about a young girl whose glioma was in an advanced state and not responding to conventional treatments. Doctors from Dana-Farber/Boston Children’s Hospital’s pediatric neuro-oncology team tried a last-resort treatment for the young patient, and, miraculously, three years later, she has not only survived, but is thriving. […] March 30, 2016

Defeat GBM Research Collaborative: Two-Year Progress Report Where We’ve Been & Where We’re Going: Past Progress and Future Developments Glioblastoma (GBM) is the most common, complex, treatment-resistant, and deadliest type of brain cancer. The pursuit of new and more effective treatments for GBM patients addresses an area of urgent, high-unmet medical need given the lack of effective treatment options currently available. GBM […] March 24, 2016

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […] March 14, 2016

Innovation, Partnerships & Progress: 2015 Scientific Summit Highlights Scientific research is the backbone of the National Brain Tumor Society’s (NBTS) mission and programs. When our legacy organizations were formed in the 1980’s the general knowledge in the medical and scientific communities regarding brain tumors and how to treat this disease was very minimal. As such, our founders realized the only way to a […] November 3, 2015